1. Home
  2. GRNQ vs MBIO Comparison

GRNQ vs MBIO Comparison

Compare GRNQ & MBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GRNQ
  • MBIO
  • Stock Information
  • Founded
  • GRNQ 2013
  • MBIO 2015
  • Country
  • GRNQ Malaysia
  • MBIO United States
  • Employees
  • GRNQ N/A
  • MBIO N/A
  • Industry
  • GRNQ EDP Services
  • MBIO Biotechnology: Pharmaceutical Preparations
  • Sector
  • GRNQ Technology
  • MBIO Health Care
  • Exchange
  • GRNQ Nasdaq
  • MBIO Nasdaq
  • Market Cap
  • GRNQ 8.9M
  • MBIO 7.3M
  • IPO Year
  • GRNQ 2018
  • MBIO N/A
  • Fundamental
  • Price
  • GRNQ $1.10
  • MBIO $2.87
  • Analyst Decision
  • GRNQ
  • MBIO Strong Buy
  • Analyst Count
  • GRNQ 0
  • MBIO 1
  • Target Price
  • GRNQ N/A
  • MBIO $100.00
  • AVG Volume (30 Days)
  • GRNQ 80.2K
  • MBIO 408.2K
  • Earning Date
  • GRNQ 03-27-2025
  • MBIO 03-10-2025
  • Dividend Yield
  • GRNQ N/A
  • MBIO N/A
  • EPS Growth
  • GRNQ N/A
  • MBIO N/A
  • EPS
  • GRNQ N/A
  • MBIO N/A
  • Revenue
  • GRNQ $2,727,344.00
  • MBIO N/A
  • Revenue This Year
  • GRNQ N/A
  • MBIO N/A
  • Revenue Next Year
  • GRNQ N/A
  • MBIO N/A
  • P/E Ratio
  • GRNQ N/A
  • MBIO N/A
  • Revenue Growth
  • GRNQ N/A
  • MBIO N/A
  • 52 Week Low
  • GRNQ $0.80
  • MBIO $2.61
  • 52 Week High
  • GRNQ $2.24
  • MBIO $74.50
  • Technical
  • Relative Strength Index (RSI)
  • GRNQ 52.12
  • MBIO 28.77
  • Support Level
  • GRNQ $0.97
  • MBIO $2.61
  • Resistance Level
  • GRNQ $1.13
  • MBIO $3.04
  • Average True Range (ATR)
  • GRNQ 0.06
  • MBIO 0.79
  • MACD
  • GRNQ 0.01
  • MBIO 0.01
  • Stochastic Oscillator
  • GRNQ 84.11
  • MBIO 6.47

About GRNQ Greenpro Capital Corp.

Greenpro Capital Corp operates and provides business solution services to small and medium-sized businesses located in Southeast Asia and East Asia, with a focus on Hong Kong, China and Malaysia, and in Thailand and Taiwan. Its range of services includes cross-border business solutions, record management services, and accounting outsourcing services. Cross-border business services include other services, tax planning, trust and wealth management, cross-border listing advisory services, and transaction services. It also operates a venture capital business. Its segments include Service business engaged in the provision of corporate advisory and business solution services; and Real estate business engaged in trading or leasing of commercial real estate properties in Hong Kong and Malaysia.

About MBIO Mustang Bio Inc.

Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapy into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.

Share on Social Networks: